DOI:
10.1055/s-00000004
Aktuelle Neurologie
Issue 03 ·
Volume 41 ·
April 2014
DOI: 10.1055/s-004-26767
Zu diesem Heft
135
Editorial
139
Diener, H. C.:
19 000 Annual Deaths in German Hospitals due to Treatment Errors?
Originalarbeit
140
Thomas, R. S.;
Voigtlaender, T.;
Lankisch, T. O.:
Secondary Sclerosing Cholangitis in Patients on the ICU and in Early Rehabilitation
Übersicht
146
Diener, H. C.;
Veltkamp, R.;
Grond, M.;
Dichgans, M.;
Endres, M.;
Weimar, C.;
Frank, B.;
Hacke, W.:
Practical Use of Novel Anticoagulants in Patients with TIA or Stroke and Atrial Fibrillation
156
Rosengarten, B.;
Mayer, K.;
Lichtenstern, C.:
Current Aspects of Sepsis Therapy on Neurointensive Care Units<break/> Part 1: General Aspects of Sepsis Therapy
162
Rösche, J.;
Pohley, I.;
Jung, S.-U.;
Benecke, R.:
Meropenem and Valproic Acid – A Combination with a High Risk of Severe Interaction
Fortschritte der Neurologischen Rehabilitation
167
Rollnik, J. D.;
Padberg, C.:
Inappropriate Medications – Improving Patient Safety in Neurological Rehabilitation by Consultation with a Pharmacist
Debatte: Pro & Kontra
171
Sommer, C.:
Corticosteroids are First Line Therapy for CIDP
173
Wenninger, S.;
Schoser, B.:
Intravenous Immunoglobulines are First Line Therapy for the Treatment of Chronic Inflammatory Demyelinating Polyneuroradiculopathy
178
Diener, H. C.:
Treatment of First Choice in CIDP – Commentary
Leserbrief
179
179
Kompetenznetz Multiple Sklerose
181
Menge, T.;
Meyer zu Hörste, G.:
Forum neurologicum
183
Erratum
e42
Diener, H. C.;
Veltkamp, R.;
Grond, M.;
Dichgans, M.;
Endres, M.;
Weimar, C.;
Frank, B.;
Hacke, W.:
Practical Use of Novel Anticoagulants in Patients with TIA or Stroke and Atrial Fibrillation
